QA: Werewolf Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001785530_2025_Werewolf_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001785530, Werewolf Therapeutics Inc

  xvar xval
0 AssetsCurrent 113,066,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,322,000
3 remainder_Assets 7,541,000
4 LiabilitiesCurrent 15,180,000
5 LiabilitiesNoncurrent 9,435,000
6 remainder_Liabilities 28,924,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,166,233
9 ResearchAndDevelopmentExpense 58,967,616
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,771,042
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 126,929,000
1 Liabilities 53,539,000
2 Expenses 78,133,849
3 Revenues 0
4 StockholdersEquity 73,390,000
5 NetIncome -73,362,807
6 ComprehensiveNetIncome -73,362,807
7 BaseVar 131,686,446
8 EconomicCapitalRatiobeforeLimitedLiability 0.960
9 EconomicCapitalRatio 2.27

Edgar->Model Mapping

Feature Distribution

Change over Time